Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$456K Sell
16,242
-108
-0.7% -$2.88K 0.19% 115
2025
Q4
$407K Sell
16,350
-365
-2% -$9.2K 0.17% 123
2025
Q3
$426K Buy
16,715
+1,427
+9% +$35.2K 0.19% 110
2025
Q2
$371K Buy
15,288
+2,269
+17% +$52.9K 0.17% 113
2025
Q1
$330K Sell
13,019
-1,000
-7% -$26.2K 0.18% 105
2024
Q4
$372K Sell
14,019
-1,294
-8% -$35.1K 0.19% 91
2024
Q3
$443K Buy
15,313
+830
+6% +$24.2K 0.23% 77
2024
Q2
$405K Buy
14,483
+2,672
+23% +$73.6K 0.23% 80
2024
Q1
$328K Sell
11,811
-357
-3% -$9.91K 0.19% 97
2023
Q4
$350K Buy
12,168
+2,478
+26% +$74.9K 0.22% 86
2023
Q3
$321K Buy
9,690
+231
+2% +$8.17K 0.23% 84
2023
Q2
$347K Buy
9,459
+405
+4% +$15.8K 0.24% 81
2023
Q1
$369K Sell
9,054
-500
-5% -$21.6K 0.28% 68
2022
Q4
$490K Sell
9,554
-323
-3% -$15.5K 0.4% 49
2022
Q3
$432K Buy
9,877
+32
+0.3% +$1.55K 0.4% 46
2022
Q2
$516K Buy
9,845
+39
+0.4% +$1.99K 0.51% 36
2022
Q1
$508K Sell
9,806
-352
-3% -$18.3K 0.41% 46
2021
Q4
$600K Buy
10,158
+349
+4% +$17.3K 0.45% 39
2021
Q3
$422K Buy
9,809
+1
+0% +$44 0.34% 57
2021
Q2
$384K Buy
9,808
+299
+3% +$11.6K 0.3% 60
2021
Q1
$345K Buy
9,509
+708
+8% +$25.1K 0.29% 62
2020
Q4
$324K Buy
8,801
+195
+2% +$7.15K 0.3% 66
2020
Q3
$300K Buy
8,606
+760
+10% +$26.6K 0.32% 62
2020
Q2
$243K Buy
7,846
+630
+9% +$21.4K 0.28% 67
2020
Q1
$223K Buy
+7,216
New +$246K 0.31% 61

Other funds holding PFE

Element Wealth's PFE Position: Q1 2026 in Review

Element Wealth reduced its Pfizer (PFE) stake by 0.66% in Q1 2026, selling an estimated $2.88K and leaving 16,242 shares worth $456K. The position accounts for 0.19% of the portfolio, ranked #115.

Element Wealth first reported a position in PFE in Q1 2020 and has held it in 25 quarters since. The position peaked at $600K in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Element Wealth held 16,242 shares of Pfizer worth $456K as of Q1 2026.
  • Element Wealth sold 108 Pfizer shares in Q1 2026, an estimated $2.88K.
  • Pfizer made up 0.19% of Element Wealth's portfolio in Q1 2026, its #115 holding.
  • Element Wealth first reported a position in Pfizer in Q1 2020 and has held it in 25 quarters since.
  • Element Wealth's Pfizer position peaked at $600K in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Element Wealth's 13F filing for Q1 2026, filed 4 May 2026.